Literature DB >> 28566467

Diagnosis and management of inflammatory bowel disease in children.

Stephanie B Oliveira1, Iona M Monteiro2.   

Abstract

Inflammatory bowel diseases (IBD), including Crohn's disease and ulcerative colitis, are lifelong conditions that often begin in childhood. The implications of IBD are of particular importance in children because of the potential negative effects on growth, development, psychosocial function, and overall wellbeing. The key management strategy is to achieve sustained control of intestinal inflammation and monitor for potential complications of the disease and side effects of therapies. Overall, the evidence on the management of IBD in children is less extensive than in adults, but good quality multicenter studies and various guidelines and society consensus statements are available. This review summarizes the evidence on the pathophysiology, diagnosis, and approaches to management of children and adolescents with IBD. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28566467      PMCID: PMC6888256          DOI: 10.1136/bmj.j2083

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  175 in total

Review 1.  Treatment of inflammatory bowel disease in childhood: best available evidence.

Authors:  Johanna C Escher; Jan A J M Taminiau; Edward E S Nieuwenhuis; Hans A Büller; Richard J Grand
Journal:  Inflamm Bowel Dis       Date:  2003-01       Impact factor: 5.325

2.  Health-related quality of life in youth with Crohn disease: role of disease activity and parenting stress.

Authors:  Wendy N Gray; Shana L Boyle; Danielle M Graef; David M Janicke; Christopher D Jolley; Lee A Denson; Robert N Baldassano; Kevin A Hommel
Journal:  J Pediatr Gastroenterol Nutr       Date:  2015-06       Impact factor: 2.839

Review 3.  Methotrexate for the Management of Crohn's Disease in Children.

Authors:  Lisa A Scherkenbach; Janice L Stumpf
Journal:  Ann Pharmacother       Date:  2015-10-27       Impact factor: 3.154

4.  Induction and maintenance infliximab therapy for the treatment of moderate-to-severe Crohn's disease in children.

Authors:  Jeffrey Hyams; Wallace Crandall; Subra Kugathasan; Anne Griffiths; Allan Olson; Jewel Johanns; Grace Liu; Suzanne Travers; Robert Heuschkel; James Markowitz; Stanley Cohen; Harland Winter; Gigi Veereman-Wauters; George Ferry; Robert Baldassano
Journal:  Gastroenterology       Date:  2006-12-03       Impact factor: 22.682

5.  Long-term outcomes of restorative proctocolectomy in children with ulcerative colitis.

Authors:  Mikko P Pakarinen; Johanna Natunen; Merja Ashorn; Antti Koivusalo; Pieta Turunen; Risto J Rintala; Kaija-Leena Kolho
Journal:  Pediatrics       Date:  2009-05       Impact factor: 7.124

6.  East-West gradient in the incidence of inflammatory bowel disease in Europe: the ECCO-EpiCom inception cohort.

Authors:  J Burisch; N Pedersen; S Čuković-Čavka; M Brinar; I Kaimakliotis; D Duricova; O Shonová; I Vind; S Avnstrøm; N Thorsgaard; V Andersen; S Krabbe; J F Dahlerup; R Salupere; K R Nielsen; J Olsen; P Manninen; P Collin; E V Tsianos; K H Katsanos; K Ladefoged; L Lakatos; E Björnsson; G Ragnarsson; Y Bailey; S Odes; D Schwartz; M Martinato; G Lupinacci; M Milla; A De Padova; R D'Incà; M Beltrami; L Kupcinskas; G Kiudelis; S Turcan; O Tighineanu; I Mihu; F Magro; L F Barros; A Goldis; D Lazar; E Belousova; I Nikulina; V Hernandez; D Martinez-Ares; S Almer; Y Zhulina; J Halfvarson; N Arebi; S Sebastian; P L Lakatos; E Langholz; P Munkholm
Journal:  Gut       Date:  2013-04-20       Impact factor: 23.059

7.  Low-dose 6-mercaptopurine in inflammatory bowel disease is associated with minimal hematologic toxicity.

Authors:  C N Bernstein; L Artinian; P A Anton; F Shanahan
Journal:  Dig Dis Sci       Date:  1994-08       Impact factor: 3.199

8.  Infliximab therapy in 30 patients with refractory pediatric crohn disease with and without fistulas in The Netherlands.

Authors:  Lissy de Ridder; Johanna C Escher; Jan Bouquet; Joachim J Schweizer; Edmond H H M Rings; Jules J M Tolboom; Roderick H J Houwen; Obbe F Norbruis; Bert H F Derkx; Jan A J M Taminiau
Journal:  J Pediatr Gastroenterol Nutr       Date:  2004-07       Impact factor: 2.839

9.  Rising incidence of pediatric inflammatory bowel disease in Scotland.

Authors:  Paul Henderson; Richard Hansen; Fiona L Cameron; Kostas Gerasimidis; Pam Rogers; W Michael Bisset; Emma L Reynish; Hazel E Drummond; Niall H Anderson; Johan Van Limbergen; Richard K Russell; Jack Satsangi; David C Wilson
Journal:  Inflamm Bowel Dis       Date:  2011-06-17       Impact factor: 5.325

10.  Inflammatory bowel disease in children, an evolving problem in Kuwait.

Authors:  Wafa'a A Al-Qabandi; Eman K Buhamrah; Khaled A Hamadi; Suad A Al-Osaimi; Ahlam A Al-Ruwayeh; JohnPatrick Madda
Journal:  Saudi J Gastroenterol       Date:  2011 Sep-Oct       Impact factor: 2.485

View more
  22 in total

1.  Cumulative Inflammation Could Be a Risk Factor for Intestinal Failure in Crohn's Disease.

Authors:  Yoshifumi Watanabe; Norikatsu Miyoshi; Shiki Fujino; Hidekazu Takahashi; Naotsugu Haraguchi; Taishi Hata; Chu Matsuda; Hirofumi Yamamoto; Yuichiro Doki; Masaki Mori; Tsunekazu Mizushima
Journal:  Dig Dis Sci       Date:  2019-02-26       Impact factor: 3.199

Review 2.  Approach to the Adult Colorectal Patient with a History of Pediatric Abdominal Surgery.

Authors:  Nitin Sajankila; Anthony DeRoss; Jeremy M Lipman
Journal:  Clin Colon Rectal Surg       Date:  2022-08-12

3.  Pediatric Inflammatory Bowel Disease: A Multicenter Study of Changing Trends in Argentina Over the Past 30 Years.

Authors:  Maria Soledad Arcucci; Monica Beatriz Contreras; Julieta Gallo; Mariela Andrea Antoniska; Veronica Busoni; Cecilia Tennina; Daniel D'Agostino; Maria Hisae Kakisu; Christian Weyersberg; Marina Orsi
Journal:  Pediatr Gastroenterol Hepatol Nutr       Date:  2022-05-09

Review 4.  Crohn's disease.

Authors:  Giulia Roda; Siew Chien Ng; Paulo Gustavo Kotze; Marjorie Argollo; Remo Panaccione; Antonino Spinelli; Arthur Kaser; Laurent Peyrin-Biroulet; Silvio Danese
Journal:  Nat Rev Dis Primers       Date:  2020-04-02       Impact factor: 52.329

Review 5.  Efficacy and Safety of Infliximab in Pediatric Crohn Disease: A Systematic Review and Meta-Analysis.

Authors:  Sophia Li; Christopher Reynaert; Annie Ling Su; Sonja Sawh
Journal:  Can J Hosp Pharm       Date:  2018-06-30

Review 6.  Contrast-enhanced ultrasound of the pediatric bowel.

Authors:  Ami Gokli; Jonathan R Dillman; Paul D Humphries; Damjana Ključevšek; Hans-Joachim Mentzel; Erika Rubesova; Marcelo S Takahashi; Sudha A Anupindi
Journal:  Pediatr Radiol       Date:  2021-05-12

7.  Video capsule endoscopy in pediatric patients with Crohn's disease: a single-center experience of 180 procedures.

Authors:  Artur Nemeth; Daniel Agardh; Gabriele Wurm Johansson; Henrik Thorlacius; Ervin Toth
Journal:  Therap Adv Gastroenterol       Date:  2018-03-04       Impact factor: 4.409

8.  Predicting inflammatory bowel disease in children with abdominal pain and diarrhoea: calgranulin-C versus calprotectin stool tests.

Authors:  Anke Heida; Els Van de Vijver; Don van Ravenzwaaij; Stephanie Van Biervliet; Thalia Z Hummel; Zehre Yuksel; Gieneke Gonera-de Jong; Renate Schulenberg; Anneke Muller Kobold; Patrick Ferry van Rheenen
Journal:  Arch Dis Child       Date:  2018-03-07       Impact factor: 3.791

9.  Azathioprine dosing and metabolite measurement in pediatric inflammatory bowel disease: does one size fit all?

Authors:  Rebecca Walker; Jochen Kammermeier; Rakesh Vora; Mohamed Mutalib
Journal:  Ann Gastroenterol       Date:  2019-05-10

Review 10.  Vaccines in Children with Inflammatory Bowel Disease: Brief Review.

Authors:  Susanna Esposito; Giulia Antoniol; Marialuisa Labate; Lucrezia Passadore; Patrizia Alvisi; Valeria Daccò; Chiara Ghizzi; Carla Colombo; Nicola Principi
Journal:  Vaccines (Basel)       Date:  2021-05-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.